Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anine H. Stam is active.

Publication


Featured researches published by Anine H. Stam.


Nature Genetics | 2010

Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1

Verneri Anttila; Hreinn Stefansson; Mikko Kallela; Unda Todt; Gisela M. Terwindt; M. S. Calafato; Dale R. Nyholt; Antigone S. Dimas; Tobias Freilinger; Bertram Müller-Myhsok; Ville Artto; Michael Inouye; Kirsi Alakurtti; Mari A. Kaunisto; Eija Hämäläinen; B.B.A. de Vries; Anine H. Stam; Claudia M. Weller; A. Heinze; K. Heinze-Kuhn; Ingrid Goebel; Guntram Borck; Hartmut Göbel; Stacy Steinberg; Christiane Wolf; Asgeir Björnsson; Gudmundur Gudmundsson; M. Kirchmann; A. Hauge; Thomas Werge

Migraine is a common episodic neurological disorder, typically presenting with recurrent attacks of severe headache and autonomic dysfunction. Apart from rare monogenic subtypes, no genetic or molecular markers for migraine have been convincingly established. We identified the minor allele of rs1835740 on chromosome 8q22.1 to be associated with migraine (P = 5.38 × 10−9, odds ratio = 1.23, 95% CI 1.150–1.324) in a genome-wide association study of 2,731 migraine cases ascertained from three European headache clinics and 10,747 population-matched controls. The association was replicated in 3,202 cases and 40,062 controls for an overall meta-analysis P value of 1.69 × 10−11 (odds ratio = 1.18, 95% CI 1.127–1.244). rs1835740 is located between MTDH (astrocyte elevated gene 1, also known as AEG-1) and PGCP (encoding plasma glutamate carboxypeptidase). In an expression quantitative trait study in lymphoblastoid cell lines, transcript levels of the MTDH were found to have a significant correlation to rs1835740 (P = 3.96 × 10−5, permuted threshold for genome-wide significance 7.7 × 10−5). To our knowledge, our data establish rs1835740 as the first genetic risk factor for migraine.


Nature Genetics | 2007

C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy

Anna Richards; Arn M. J. M. van den Maagdenberg; Joanna C. Jen; David J. Kavanagh; Paula Bertram; Dirk Spitzer; M. Kathryn Liszewski; Maria Louise Barilla-Labarca; Gisela M. Terwindt; Yumi Kasai; Michael D. McLellan; Mark Gilbert Grand; Kaate R. J. Vanmolkot; Boukje de Vries; Jijun Wan; Michael J. Kane; Hafsa Mamsa; Ruth Schäfer; Anine H. Stam; Joost Haan; Paulus T. V. M. de Jong; C. W. J. M. Storimans; Mary J. van Schooneveld; Jendo A. Oosterhuis; Andreas Gschwendter; Martin Dichgans; Katya E. Kotschet; Suzanne J. Hodgkinson; Todd A. Hardy; Martin B. Delatycki

Autosomal dominant retinal vasculopathy with cerebral leukodystrophy is a microvascular endotheliopathy with middle-age onset. In nine families, we identified heterozygous C-terminal frameshift mutations in TREX1, which encodes a 3′-5′ exonuclease. These truncated proteins retain exonuclease activity but lose normal perinuclear localization. These data have implications for the maintenance of vascular integrity in the degenerative cerebral microangiopathies leading to stroke and dementias.


Nature Genetics | 2013

Genome-wide meta-analysis identifies new susceptibility loci for migraine

Verneri Anttila; Bendik S. Winsvold; Padhraig Gormley; Tobias Kurth; Francesco Bettella; George McMahon; Mikko Kallela; Rainer Malik; Boukje de Vries; Gisela M. Terwindt; Sarah E. Medland; Unda Todt; Wendy L. McArdle; Lydia Quaye; Markku Koiranen; M. Arfan Ikram; Terho Lehtimäki; Anine H. Stam; Lannie Ligthart; Juho Wedenoja; Ian Dunham; Benjamin M. Neale; Priit Palta; Eija Hämäläinen; Markus Schuerks; Lynda M. Rose; Julie E. Buring; Paul M. Ridker; Stacy Steinberg; Hreinn Stefansson

Migraine is the most common brain disorder, affecting approximately 14% of the adult population, but its molecular mechanisms are poorly understood. We report the results of a meta-analysis across 29 genome-wide association studies, including a total of 23,285 individuals with migraine (cases) and 95,425 population-matched controls. We identified 12 loci associated with migraine susceptibility (P < 5 × 10−8). Five loci are new: near AJAP1 at 1p36, near TSPAN2 at 1p13, within FHL5 at 6q16, within C7orf10 at 7p14 and near MMP16 at 8q21. Three of these loci were identified in disease subgroup analyses. Brain tissue expression quantitative trait locus analysis suggests potential functional candidate genes at four loci: APOA1BP, TBC1D7, FUT9, STAT6 and ATP5B.


Neurology | 2007

Systematic analysis of three FHM genes in 39 sporadic patients with hemiplegic migraine

B. de Vries; Tobias Freilinger; Krj Vanmolkot; Jan B. Koenderink; Anine H. Stam; Gisela M. Terwindt; Elena Babini; E. H. van den Boogerd; J.J.M.W. van den Heuvel; Rune R. Frants; Joost Haan; Michael Pusch; A.M.J.M. van den Maagdenberg; M. D. Ferrari; Martin Dichgans

Background: Familial (FHM) and sporadic (SHM) hemiplegic migraine are severe subtypes of migraine associated with transient hemiparesis. For FHM, three genes have been identified encoding subunits of a calcium channel (CACNA1A), a sodium–potassium pump (ATP1A2), and a sodium channel (SCN1A). Their role in SHM is unknown. Establishing a genetic basis for SHM may further the understanding of its pathophysiology and relationship with common types of migraine. It will also facilitate the often difficult differential diagnosis from other causes of transient hemiparesis. Methods: We systematically scanned 39 well-characterized patients with SHM without associated neurologic features for mutations in the three FHM genes. Functional assays were performed for all new sequence variants. Results: Sequence variants were identified in seven SHM patients: one CACNA1A mutation, five ATP1A2 mutations, and one SCN1A polymorphism. All six mutations caused functional changes in cellular assays. One SHM patient later changed to FHM because another family member developed FHM attacks. Conclusion: We show that FHM genes are involved in at least a proportion of SHM patients without associated neurologic symptoms. Screening of ATP1A2 offers the highest likelihood of success. Because FHM gene mutations were also found in family members with “nonhemiplegic” typical migraine with and without aura, our findings reinforce the hypothesis that FHM, SHM, and “normal” migraine are part of a disease spectrum with shared pathogenetic mechanisms.


JAMA Neurology | 2009

Episodic Ataxia Associated With EAAT1 Mutation C186S Affecting Glutamate Reuptake

Boukje de Vries; Hafsa Mamsa; Anine H. Stam; Jijun Wan; Stef L. M. Bakker; Kaate R. J. Vanmolkot; Joost Haan; Gisela M. Terwindt; Elles M. J. Boon; Bruce D. Howard; Rune R. Frants; Robert W. Baloh; Michel D. Ferrari; Joanna C. Jen; Arn M. J. M. van den Maagdenberg

BACKGROUND Episodic ataxia (EA) is variably associated with additional neurologic symptoms. At least 4 genes have been implicated. Recently, a mutation in the SLC1A3 gene encoding the glutamate transporter EAAT1 was identified in a patient with severe episodic and progressive ataxia, seizures, alternating hemiplegia, and migraine headache. The mutant EAAT1 showed severely reduced uptake of glutamate. The syndrome was designated EA6 and shares overlapping clinical features with EA2, which is caused by mutations in CACNA1A. OBJECTIVE To test the role of the SLC1A3 gene in EA. DESIGN Genetic and functional studies. We analyzed the coding region of the SLC1A3 gene by direct sequencing. SETTING Academic research. PATIENTS DNA samples from 20 patients with EA (with or without interictal nystagmus) negative for CACNA1A mutations were analyzed. MAIN OUTCOME MEASURES We identified 1 novel EAAT1 mutation in a family with EA and studied the functional consequences of this mutation using glutamate uptake assay. RESULTS We identified a missense C186S mutation that segregated with EA in 3 family members. The mutant EAAT1 showed a modest but significant reduction of glutamate uptake. CONCLUSIONS We broadened the clinical spectrum associated with SLC1A3 mutations to include milder manifestations of EA without seizures or alternating hemiplegia. The severity of EA6 symptoms appears to be correlated with the extent of glutamate transporter dysfunction.


Annals of Neurology | 2006

Severe episodic neurological deficits and permanent mental retardation in a child with a novel FHM2 ATP1A2 mutation.

Krj Vanmolkot; H. Stroink; Jan B. Koenderink; Esther E. Kors; J.J.M.W. van den Heuvel; E. H. van den Boogerd; Anine H. Stam; Joost Haan; B. de Vries; Gisela M. Terwindt; Rune R. Frants; Michel D. Ferrari; A.M.J.M. van den Maagdenberg

Attacks of familial hemiplegic migraine (FHM) are usually associated with transient, completely reversible symptoms. Here, we studied the ATP1A2 FHM2 gene in a young girl with episodes of both very severe and transient neurological symptoms that were triggered by mild head trauma as well as permanent mental retardation. Her family members suffered from hemiplegic and confusional migraine attacks.


Neurology | 2010

Shared genetic factors in migraine and depression Evidence from a genetic isolate

Anine H. Stam; B. de Vries; A. C. J. W. Janssens; Krj Vanmolkot; Yurii S. Aulchenko; Peter Henneman; B. A. Oostra; Rune R. Frants; A.M.J.M. van den Maagdenberg; M. D. Ferrari; C. M. van Duijn; Gisela M. Terwindt

Objective: To investigate the co-occurrence of migraine and depression and assess whether shared genetic factors may underlie both diseases. Methods: Subjects were 2,652 participants of the Erasmus Rucphen Family genetic isolate study. Migraine was diagnosed using a validated 3-stage screening method that included a telephone interview. Symptoms of depression were assessed using the Center for Epidemiologic Studies Depression scale and the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D). The contribution of shared genetic factors in migraine and depression was investigated by comparing heritability estimates for migraine with and without adjustment for symptoms of depression, and by comparing the heritability scores of depression between migraineurs and controls. Results: We identified 360 migraine cases: 209 had migraine without aura (MO) and 151 had migraine with aura (MA). Odds ratios for depression in patients with migraine were 1.29 (95% confidence interval [CI] 0.98–1.70) for MO and 1.70 (95% CI 1.28–2.24) for MA. Heritability estimates were significant for all migraine (0.56), MO (0.77), and MA (0.96), and decreased after adjustment for symptoms of depression or use of antidepressant medication, in particular for MA. Comparison of the heritability scores for depression between patients with migraine and controls showed a genetic correlation between HADS-D score and MA. Conclusions: There is a bidirectional association between depression and migraine, in particular migraine with aura, which can be explained, at least partly, by shared genetic factors.


Cephalalgia | 2009

First Mutation in the Voltage-Gated Nav1.1 Subunit Gene SCN1A with Co-Occurring Familial Hemiplegic Migraine and Epilepsy

M-J Castro; Anine H. Stam; Carolina Lemos; B.B.A. de Vries; Krj Vanmolkot; José Barros; Gisela M. Terwindt; Rune R. Frants; Jorge Sequeiros; Ferrari; José Pereira-Monteiro; Amjm van den Maagdenberg

Almost all mutations in the SCN1A gene, encoding the α1 subunit of neuronal voltage-gated Nav1.1 sodium channels, are associated with severe childhood epilepsy. Recently, two mutations were identified in patients with pure familial hemiplegic migraine (FHM). Here, we identified a novel SCN1A L263V mutation in a Portuguese family with partly co-segregating hemiplegic migraine and epilepsy. The L263V mutation segregated in five FHM patients, three of whom also had epileptic attacks, occurring independently from their hemiplegic migraine attacks. L263V is the first SCN1A mutation associated with FHM and co-occurring epilepsy in multiple mutation carriers, and is the clearest molecular link between migraine and epilepsy thus far. The results extend the clinical spectrum associated with SCN1A mutations and further strengthen the molecular evidence that FHM and epilepsy share, at least in part, similar molecular pathways.


Journal of Neurology, Neurosurgery, and Psychiatry | 2009

Early seizures and cerebral oedema after trivial head trauma associated with the CACNA1A S218L mutation

Anine H. Stam; Gert Jan Luijckx; Bwee Tien Poll-The; Ib Ginjaar; Rune R. Frants; Joost Haan; Michel D. Ferrari; Gisela M. Terwindt; A.M.J.M. van den Maagdenberg

Objective: To study the clinical spectrum of CACNA1A S218L mutation carriers with special attention to “early seizures and cerebral oedema after trivial head trauma (ESCEATHT)”, a combination of symptoms which resembles the “juvenile head trauma syndrome”. Patients and methods: In two patients with ESCEATHT all exons of CACNA1A were sequenced. Both patients also had hemiplegic migraine and ataxia. Subsequently, we screened the literature for S218L mutation carriers. Results: In both patients, a de novo S218L mutation in the CACNA1A gene was found. In addition, we identified 11 CACNA1A S218L carriers from the literature. Of these 13 S218L mutation carriers, 12 (92%) had ataxia or cerebellar symptoms and nine (69%) had hemiplegic migraine that could be triggered by trivial head trauma. Three mutation carriers had the complete ESCEATHT phenotype. Seven (54%) had seizures (four had early post-traumatic seizures) and five (38%) had oedema as detected by MRI/CT. Conclusions: The CACNA1A S218L mutation is associated with familial hemiplegic migraine, ataxia and/or ESCEATHT. A minority of S218L mutation carriers have the complete ESCEATHT phenotype but a high percentage of patients had one or more ESCEATHT symptoms. As the S218L mutation enhances the propensity for cortical spreading depression (CSD), we postulate a role for CSD not only in hemiplegic migraine but also in early seizures and cerebral oedema after trivial head trauma. As this combination of symptoms is part of the unexplained “juvenile head trauma syndrome”, a similar molecular mechanism may underlie this disorder.


Cephalalgia | 2009

Migraine and genetic and acquired vasculopathies

Anine H. Stam; Joost Haan; Amjm van den Maagdenberg; Ferrari; Gisela M. Terwindt

It is remarkable that migraine is a prominent part of the phenotype of several genetic vasculopathies, including cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL), retinal vasculopathy with cerebral leukodystrophy (RVCL) and hereditary infantile hemiparessis, retinal arteriolar tortuosity and leukoencephalopahty (HIHRATL). The mechanisms by which these genetic vasculopathies give rise to migraine are still unclear. Common genetic susceptibility, increased susceptibility to cortical spreading depression (CSD) and vascular endothelial dysfunction are among the possible explanations. The relation between migraine and acquired vasculopathies such as ischaemic stroke and coronary heart disease has long been established, further supporting a role of the (cerebral) blood vessels in migraine. This review focuses on genetic and acquired vasculopathies associated with migraine. We speculate how genetic and acquired vascular mechanisms might be involved in migraine.

Collaboration


Dive into the Anine H. Stam's collaboration.

Top Co-Authors

Avatar

Gisela M. Terwindt

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michel D. Ferrari

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rune R. Frants

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nadine Pelzer

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge